<DOC>
	<DOCNO>NCT02125266</DOCNO>
	<brief_summary>This study intend evaluate safety V404 PDS patient chronic non-infectious uveitis . Secondarily , study evaluate whether V404 PDS provide clinically measurable benefit extend period time patient chronic non-infectious uveitis .</brief_summary>
	<brief_title>Safety Preliminary Efficacy Study V404 PDS Uveitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Uveitis , Posterior</mesh_term>
	<mesh_term>Uveitis , Intermediate</mesh_term>
	<mesh_term>Pars Planitis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>18 year age old Confirmed diagnosis active uveitis Sufficient lens/media clarity Meet bestcorrected visual acuity criterion Willing able use contraception Pregnant , breast feeding Uncontrolled glaucoma Intraocular surgery periocular/intraocular injection within 6 week Periocular intraocular steroid within 3 month Prior vitrectomy Prior corneal transplant Prior fluocinolone implant Allergy sensitivity study drug Participation trial within 30 day Abnormal liver function History positive serum tuberculosis test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>